Authorship note: zm, jy, hy, and sf contributed equally to this work. conflict of interest: the authors have declared that no conflict of interest exists

HIGHLIGHTS

• who: Zihang Mai and collaborators from the Departmentsen University Cancer Center, Guangzhou, China have published the paper: Authorship note: ZM, JY, HY, and SF contributed equally to this work. Conflict of interest: The authors have declared that no conflict of interest exists, in the Journal: (JOURNAL)
• how: The results showed that the 3 -gene signature was a promising biomarker for distinguishing an ESCC subtype with a poor prognosis for patients who might be potential beneficiaries of immunotherapies.
• future: Mutation trajectories are still obscure in ESCC and more investigations are needed.

SUMMARY . . .

 

If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.